Original Article, 120-126 | DOI: 10.53260/grem.201029 The sequential use of raloxifene and ibandronate in postmenopausal osteoporosis. Bone and metabolic impact. Webinar Marta Ferrer, Juan Tarín, Miguel-Ángel García-Pérez, Antonio Cano